Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M642Revenue $M13.5Net Margin (%)-490.3Z-Score16.3
Enterprise Value $M534EPS $-1.4Operating Margin %-145.1F-Score4
P/E(ttm))0Cash Flow Per Share $-0.1Pre-tax Margin (%)-490.7Higher ROA y-yN
Price/Book5.310-y EBITDA Growth Rate %-19.4Quick Ratio9.7Cash flow > EarningsY
Price/Sales33.05-y EBITDA Growth Rate %-10.9Current Ratio9.7Lower Leverage y-yY
Price/Cash Flow0y-y EBITDA Growth Rate %0ROA % (ttm)-74.8Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)3ROE % (ttm)-125.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M60.2ROI % (ttm)-83.0Gross Margin Increase y-yN

Gurus Latest Trades with INO

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
INOJean-Marie Eveillard 2014-03-31 Sold Out $9.76 - $15.28
($11.92)
$ 10.63-11%Sold Out0
INOJean-Marie Eveillard 2013-12-31 Buy $6.92 - $11.88
($8.28)
$ 10.6328%New holding, 250000 sh.250,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

INO is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


INO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
COLLINS MORTONDirector 2014-08-21Buy8,000$10.016.19 view
COLLINS MORTONDirector 2014-08-20Buy40,600$9.749.14 view
Sardesai NiranjanCOO 2014-08-12Buy2,550$8.722.18 view
Kim Jong JosephCEO 2014-08-12Buy250,000$9.0617.33 view
Kim Jong JosephCEO 2014-04-15Buy6,250$918.11 view
COLLINS MORTONDirector 2013-11-13Buy63,625$7.2846.02 view
Bagarazzi MarkChief Medical Officer 2013-04-16Buy15,000$2.24374.55 view
Kim Jong JosephCEO, 10% Owner 2013-04-02Buy22,500$2431.5 view
Cabrera AngelDirector 2013-03-22Buy10,000$2.16392.13 view
Sardesai NiranjanCOO 2013-03-20Buy6,250$2.12401.42 view

Press Releases about INO :

    Quarterly/Annual Reports about INO:

    News about INO:

    Articles On GuruFocus.com
    Inovio CEO Invests in 250,000 Shares of Company Stock Aug 13 2014 
    comment on INO May 10 2013 
    Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU Apr 07 2013 
    Weekly CFO Buys Highlight: ZBB, INO, LPR, PMC, FGP, PRMW Jun 17 2012 
    Weekly CFO Buys Highlight: BWEN, EMC, INO, DCTH, ACCO Jun 11 2012 
    Any opinions regarding Apr 12 2010 

    More From Our Partners
    3 Transportation Stocks Moving The Industry Upward Aug 21 2014 - THESTREET

    More From Other Websites
    INOVIO PHARMACEUTICALS, INC. Financials Aug 19 2014
    Inovio CEO Invests in 250,000 Shares of Company Stock Aug 13 2014
    Inovio Pharmaceuticals (INO) Marked As A Dead Cat Bounce Stock Aug 12 2014
    Why Inovio Pharmaceuticals (INO) Stock Is Declining Today Aug 11 2014
    Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results Aug 11 2014
    Inovio Pharmaceuticals Reports 2014 Second Quarter Financial Results Aug 11 2014
    Q2 2014 Inovio Pharmaceuticals Inc Earnings Release - 09:00 am ET Aug 11 2014
    INOVIO PHARMACEUTICALS, INC. Files SEC form 10-Q, Quarterly Report Aug 11 2014
    Inovio Pharmaceuticals to Host Second Quarter 2014 Earnings Webcast Live on Monday, August 11, 2014 Aug 08 2014
    INOVIO PHARMACEUTICALS, INC. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an... Aug 06 2014
    Inovio Pharmaceuticals to Host Second Quarter 2014 Financial Results Call on August 11, 2014 Aug 01 2014
    Inovio Data Not A Home Run, But Got Company In Great Scoring Position Jul 25 2014
    Inovio Pharma upgraded by Aegis Capital Jul 24 2014
    Inovio upgraded to Buy from Hold at Aegis Jul 24 2014
    Perilous Reversal Stock: Inovio Pharmaceuticals (INO) Jul 24 2014
    Is Inovio Undervalued After Positive HPV Therapy Results? Jul 23 2014
    INOVIO PHARMACEUTICALS, INC. Files SEC form 8-K, Regulation FD Disclosure Jul 23 2014
    Inovio Declares Spin-Laden Victory With DNA Vaccine Jul 23 2014
    Inovio Pharmaceuticals HPV Immunotherapy Achieves Primary Efficacy Endpoint in Randomized Phase II... Jul 23 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK